Operating Lease, Right-of-Use Asset of Black Diamond Therapeutics, Inc. from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Black Diamond Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • Black Diamond Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $16,669,000, a 16% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Black Diamond Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $16,669,000 -$3,098,000 -16% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $17,460,000 -$3,055,000 -15% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $18,240,000 -$3,012,000 -14% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $19,009,000 -$2,971,000 -14% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $19,767,000 -$2,931,000 -13% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 $20,515,000 -$2,891,000 -12% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $21,252,000 -$2,852,000 -12% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $21,980,000 -$2,814,000 -11% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $22,698,000 -$2,841,000 -11% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $23,406,000 -$2,819,000 -11% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $24,104,000 -$3,030,000 -11% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $24,794,000 -$2,911,000 -11% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $25,539,000 -$2,826,000 -10% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $26,225,000 +$13,044,000 +99% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $27,134,000 +$13,336,000 +97% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 $27,705,000 +$19,303,000 +230% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $28,365,000 +$19,902,000 +235% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $13,181,000 +$12,799,000 +3351% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $13,798,000 +$13,369,000 +3116% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $8,402,000 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 $8,463,000 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $382,000 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 $429,000 31 Mar 2020 10-Q 12 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.